Abbott to Invest More in R&D in Emerging Markets, CEO Says
Abbott Laboratories (ABT) plans to invest more in research and development in emerging markets, Chief Executive Officer Miles White said. He spoke at a Financial Times pharmaceutical industry conference in London.
To contact the reporter on this story: Makiko Kitamura in London at firstname.lastname@example.org
To contact the editor responsible for this story: Phil Serafino at email@example.com